SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

Terra Luna Classic is experiencing significant community buzz driven by anticipation for upcoming validator upgrades and potential token supply reduction measures. Investors are debating the long-term utility of the project, while social media sentiment remains polarized between those hoping for a major recovery and those skeptical of its historical volatility.

Far below the surface, where light no longer reaches and noise collapses into silence, the Sperm Whale endures.  It does not rely on speed or spectacle. It survives through mass, intelligence, and absolute awareness of its surroundings.  This project is shaped by the same principle — strength formed under pressure, movement guided by understanding, and conviction built where others cannot remain.  While the surface reacts, the deep decides.

The Sperm Whale

The Sperm Whale crypto community remains highly active as investors push for a breakout, with social sentiment focused on aggressive buy-the-dip strategies and hopes of erasing zeros. Despite skepticism surrounding its volatility and rotation into competing meme projects, supporters are actively organizing on social platforms to defend the price floor and fuel a potential move toward previous highs.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is currently trending due to intense community debate surrounding its valuation and the effectiveness of its AI-driven ad engine, Axon, as investors weigh strong fundamental performance against broader sector skepticism. Community discussion is sharply divided between bulls highlighting upcoming earnings potential and margin expansion, and critics pointing to extreme volatility and concerns over institutional selling pressure.

PG&E Corp. operates as a holding company, which engages in generation, transmission, and distribution of electricity and natural gas to customers. It specializes in energy, utility, power, gas, electricity, solar, and sustainability. The company was founded on November 17, 1995 and is headquartered in Oakland, CA.

PG&E Corp.

PG&E (PCG) is trending as investors weigh strong data center energy demand against lingering concerns over wildfire-related liabilities. The community is actively discussing the stock's long-term infrastructure investment potential and its role as a defensive utility play amid ongoing market volatility.

Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.

Biohaven Ltd

Biohaven Pharmaceutical Holding Company Ltd

Biohaven is currently a focal point for investors as the company navigates a critical FDA appeal process for its spinocerebellar ataxia therapy, with the community actively speculating on the impact of recent leadership changes at the FDA on potential drug re-reviews. Discussions are dominated by the search for a new path forward following a prior rejection, balanced against strong institutional positioning and institutional conviction that the company's broader pipeline remains significantly undervalued.

What is Chronotech? Chrono.tech provides blockchain-based solutions for recruitment, HR and payment processes, reducing the barriers to accessing work and transferring funds securely in the global labor marketplace. The project’s suite of services - and native governance token TIME - are hosted on multiple blockchains and include LaborX.com, a peer-to-peer freelancer marketplace, TimeX.io, a Plasma-based cryptocurrency exchange; AUDT, an Australian dollar-backed stablecoin; and PaymentX, a crypto invoicing and payroll solution.  TIME token The TIME token is the native token of the Chrono.tech ecosystem and can be used within its products, e.g. to secure premium account status, as well as staking TIME on TimeWarp.finance to receive the revenues generated by all services. In November 2020, the original TIME token was upgraded to the new ERC677 standard, enabling it to be integrated with other DeFi protocols, allowing lower-cost transactions, and providing other advantages, while remaining fully ERC20-compatible. The new TIME 2.0 token contract also included up-to-date metadata about the project.  Chrono.tech products and ecosystem Chrono.tech aims to solve a series of problems in the global recruitment and employment markets. LaborX is Chrono.tech’s freelance work portal. The service allows freelancers and customers to organise work via digital agreements, powered by smart contracts. All payments are escrowed and made in cryptocurrency. Once a job is completed, escrowed payments are released automatically. A dispute resolution service is available in case of disagreement. TimeX is Chrono.tech’s cryptocurrency exchange. TimeX is a hybrid Plasma-based exchange that offers the benefits of both centralised and decentralised technologies. Use of Plasma allows for fast, secure trading of digital assets. The conventional interface provides a user-friendly trading experience. Based in Australia, TimeX is licensed and compliant with rules and best practices required by AUSTRAC, the country’s financial intelligence agency. TimeX is listed on CoinMarketCap https://coinmarketcap.com/exchanges/timex/ TimeWarp is the ecosystem’s DeFi yield farming application where TIME holders can stake their token to earn revenues generated by all products of the Chrono.tech product range. All 100% of revenues generated are being distributed to TIME holders on a weekly basis. AUDT is a stablecoin, hosted on the Ethereum blockchain and backed 1:1 with Australian dollars (AUD). Use of AUDT enables traders to move money into and out of the blockchain ecosystem from an Australian bank account, to store value in AUD on the blockchain and transfer funds anywhere in the world, quickly and easily. AUDT is one of the key fiat currencies traded on TimeX. AUDT is fully compliant with AUSTRAC requirements and undergoes regular audits conducted by a licensed, third party accounting firm. PaymentX is a multi-currency crypto payroll solution that enables individuals as well as businesses to integrate crypto payments into their day-to-day invoice processes. Contractors can submit professional invoices and specify a crypto wallet for payment. Companies can pay multiple invoices with one click, while the software converts the dollar-equivalent amount due into crypto automatically at the point of transaction, avoiding the need for manual calculations. TimeBridge is an in-house developed multi-blockchain tokenbridge that supports multiple blockchains such as Ethereum and BSC. It allows transferring of TIME tokens between networks.

Chronobank

Chronobank (TIME) is seeing renewed interest due to its extremely low circulating supply of 710,000 coins and potential for significant volatility. Community discussion is split between speculative bulls anticipating a major price rally and skeptics concerned about historical pump-and-dump patterns and recent protocol hacks.

Daddy Darth Vader

The $DARTH token is currently trending as community members rally behind a "Daddy Wars" narrative against other projects, emphasizing a shift toward community-driven growth. Participants are actively debating the token's potential as a "May 4th" play, with many focused on aggressive social media promotion to gain momentum.

Linea is the Layer 2 built from first principles to strengthen Ethereum and the entire ETH economy. Every aspect of its design—from its productive ETH burn mechanics, and capital efficient native yield, to its underlying Ethereum-equivalent zk tech—amplifies the value and utility of Ethereum Mainnet. All of this is backed by the largest ecosystem fund in the space, managed by the most trusted Ethereum builders. With institutional-grade infrastructure, and deep integration across DeFi, Linea is the best chain for ETH capital, where every transaction and every block strengthens Ethereum. Linea is where Ethereum wins.

Linea

Linea is trending due to community excitement surrounding its role as a key Ethereum-based partner for upcoming SWIFT cross-border payment pilots. Supporters are highlighting the network's dual-burn fee mechanism and institutional ties as major catalysts, though discussions remain polarized with some traders expressing caution regarding token unlocks and price volatility.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is attracting significant investor attention as it prepares for a high-profile oral presentation at Digestive Disease Week, where community members anticipate the release of compelling clinical data on pancreatic cancer. The stock is currently trending due to a combination of clinical trial progress and institutional accumulation, with many investors expressing optimism about its potential for long-term growth and upcoming catalysts.

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.

Legend Biotech Corp - ADR

Legend Biotech

Legend Biotech is trending due to heightened speculation surrounding a potential buyout, following reports that the company has engaged financial advisors to evaluate unsolicited takeover interest. Community members are actively analyzing the company's valuation, J&J's partnership dynamics, and the commercial outlook for its blockbuster therapy, Carvykti, as a potential catalyst for an acquisition.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is First Trust Materials AlphaDEX ETF (FXZ) a Strong ETF Right Now?

Should You Invest in the First Trust Materials AlphaDEX ETF (FXZ)?

 ETFs in Spotlight as Trump Moves to Mobilize Defense Production Act

Trump invokes the Defense Production Act to secure phosphorus and glyphosate. MOO could gain as domestic agricultural and materials players ramp up. 

<ul class="summary-bullets"><li>The initiative to refocus on rare earths came alongside Q3 earnings, which met EPS estimates but missed on revenue.</li><li>CEO Lourenco Goncalves stated the firm saw the “renewed importance” of rare earths, which drove the company to re-focus on the “potential opportunity.”</li><li>He said Cleveland-Cliffs plans to leverage two U.S. sites, in Michigan and Minnesota, identified as having the strongest rare-earth potential.</li></ul>Cleveland-Cliffs’ (CLF) stock rose in pre-market trade on Monday,&nbsp;on track to hit more than a year high, and was among the top trending tickers on Stocktwits after its CEO, Lourenco Goncalves, stated the company could expand into rare-earths, a comment made alongside its third-quarter earnings release.CLF’s stock rose&nbsp;over 15% in pre-market trade,&nbsp;trading at levels not seen since&nbsp;July 2024,&nbsp;with retail sentiment on Stocktwits in ‘bullish’ territory. Chatter rose to ‘high’ from ‘normal’ levels over the past day.&nbsp;<h2 class="st-heading-2">Why Was Cleveland-Cliffs’ Stock Rising In Pre-Market Trade?</h2>The rally came despite the company reporting third-quarter (Q3) earnings largely in line with expectations. Cleveland-Cliffs posted a loss per share of $0.45, matching analyst forecasts, while revenue reached $4.7 million, slightly below the consensus estimate of $4.8 million, according to Koyfin data.The shares rallied on Goncalves stating that rare-earths could represent a strategic growth area for the company. "Beyond steelmaking, the renewed importance of rare earths has driven us to re-focus on this potential opportunity at our upstream mining assets," he said.&nbsp;<blockquote>"It is our obligation to do so as a company with our geological footprint. Two sites in Michigan and Minnesota show the most potential, with geological surveys indicating key rare-earth mineralization."&nbsp; – Lourenco Goncalves, CEO, Cleveland-Cliffs</blockquote>He highlighted the broader implications for manufacturing and national strategy, amid the trade tensions between the U.S. and China. "If successful, it would align Cleveland-Cliffs with the broader national strategy for critical material independence, similar to what we achieved in steel,” he said. “American manufacturing shouldn’t rely on China or any foreign nation for essential minerals, and Cliffs intends to be part of the solution.”The comments come as interest in rare earths has surged after China announced new export controls around rare earth elements, technologies, and sand processing equipment earlier this month.&nbsp;Shares of Cleveland-Cliffs have gained nearly 40% this year and around 2% in the last 12 months.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/bitcoin-price-tops-110000-as-crypto-market-rebounds/ch6CMKdR3Y1">Bitcoin Tops $110,000 As Crypto Market Rebounds On Trump’s Optimism Over China Trade Talks</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Cleveland-Cliffs Inc. Mining company logo seen displayed on a smartphone. (Photo Illustration by Igor Golovniov/SOPA Images/LightRocket via Getty Images)

CLF Stock Rises After Cleveland-Cliffs CEO Signals Shift Toward Rare-Earths

The initiative to refocus on rare earths came alongside Q3 earnings, which met EPS estimates but missed on revenue.

Current Price	$79.83
Prev Close	$79.94
Open	$80.12
Dividend Yield	N/A
50-Day Moving Average	$77.04
Beta	N/A
Avg. Volume	49,056.80
PE Ratio	N/A

52-Week High	$80.84
52-Week Low	$52.08
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

FXZ
First Trust Exchange-Traded Fund III - First Trust Materials AlphaDEX Fund

Feed

News

Sentiment

Fundamentals

Info

Latest FXZ News

FXZFirst Trust Exchange-Traded Fund III - First Trust Materials AlphaDEX Fund